Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.
Yokoyama Y, Fukunaga K, Fukuda Y, Tozawa K, Kamikozuru K, Ohnishi K, Kusaka T, Kosaka T, Hida N, Ohda Y, Miwa H, Matsumoto T. Yokoyama Y, et al. Among authors: kamikozuru k. Dig Dis Sci. 2007 Oct;52(10):2725-31. doi: 10.1007/s10620-006-9560-z. Epub 2007 Apr 3. Dig Dis Sci. 2007. PMID: 17404876
Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.
Matsumoto T, Fukunaga K, Kamikozuru K, Tozawa K, Yokoyama Y, Kusaka T, Onishi K, Miwa H, Nakamura S. Matsumoto T, et al. Among authors: kamikozuru k. Transfus Med Hemother. 2008;35(1):18-23. doi: 10.1159/000111763. Epub 2007 Dec 21. Transfus Med Hemother. 2008. PMID: 21547106 Free PMC article.
The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy.
Yokoyama Y, Fukunaga K, Ikeuchi H, Kamikozuru K, Hida N, Ohda Y, Iimuro M, Yoshida K, Kikuyama R, Kato K, Nagase K, Nakamura S, Miwa H, Matsumoto T. Yokoyama Y, et al. Among authors: kamikozuru k. Cytokine. 2011 Nov;56(2):466-70. doi: 10.1016/j.cyto.2011.06.021. Epub 2011 Jul 28. Cytokine. 2011. PMID: 21802311
Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.
Kikuyama R, Fukunaga K, Kawai M, Yokoyama Y, Kamikozuru K, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Kato K, Kono T, Nogami K, Nagase K, Nakamura S, Takei Y, Miwa H, Matsumoto T. Kikuyama R, et al. Among authors: kamikozuru k. Ther Apher Dial. 2011 Aug;15(4):360-6. doi: 10.1111/j.1744-9987.2011.00968.x. Ther Apher Dial. 2011. PMID: 21884470
Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.
Yoshida K, Fukunaga K, Ikeuchi H, Kamikozuru K, Hida N, Ohda Y, Yokoyama Y, Iimuro M, Takeda N, Kato K, Kikuyama R, Nagase K, Hori K, Nakamura S, Miwa H, Matsumoto T. Yoshida K, et al. Among authors: kamikozuru k. Inflamm Bowel Dis. 2012 Sep;18(9):1617-23. doi: 10.1002/ibd.21928. Epub 2011 Nov 13. Inflamm Bowel Dis. 2012. PMID: 22081474 Clinical Trial.
Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with Cellsorba in patients with active ulcerative colitis.
Fukunaga K, Kamikozuru K, Yokoyama Y, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Kikuyama R, Kato K, Nagase K, Nakamura S, Miwa H, Matsumoto T. Fukunaga K, et al. Among authors: kamikozuru k. J Clin Apher. 2011 Dec;26(6):326-31. doi: 10.1002/jca.20314. Epub 2011 Nov 14. J Clin Apher. 2011. PMID: 22083887 Clinical Trial.
26 results